[1]ACSMedicinalChemistryLetters,2012,vol.3,#7,p.550-554
[1]ChemicalCommunications,2009,#48,p.7581-7583
[2]ACSMedicinalChemistryLetters,2012,vol.3,#7,p.550-554
[1]EuropeanJournalofOrganicChemistry,2014,vol.2014,#3,p.511-514
[2]EuropeanJournalofOrganicChemistry,2014,vol.2014,#3,p.511-514
[1]TetrahedronLetters,2010,vol.51,#50,p.6549-6551
[1]Synthesis,1984,vol.NO.10,p.862-865
[1]ArchivesofPharmacalResearch,2011,vol.34,p.357-367
[2]ACSMedicinalChemistryLetters,2012,vol.3,p.550-554
[3]JournalandProceedings-RoyalSocietyofNewSouthWales,1932,vol.66,p.171,178
[4]BioorganicandMedicinalChemistryLetters,2000,vol.10,p.483-486
[5]EuropeanJournalofMedicinalChemistry,2019,vol.173,p.15-31
[1]JournaloftheChemicalSociety,1955,p.2536
[1]Synthesis,1987,p.401-404
[1]Synthesis,1984,vol.NO.10,p.862-865
[1]JournalofMedicinalChemistry,2006,vol.49,p.947-954
Title: Multiple tyrosine metabolites are GPR35 agonists.
Journal: Scientific reports 20120101